Neogen Corporation

NASDAQ:NEOG

Medical - Diagnostics & Research

Healthcare
$11.08 +1.79%

+$0.16 today

Market cap
$2.42B
Beta
1.80
P/E (TTM)
-3.3
EPS (TTM)
-$2.80
52W Low $4.56High $11.43

Volume 1.79M

Average 2.53M

NEOG Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Neogen CorporationNASDAQ: NEOG

Retained Earnings · Q1 FY2027 · quarter ended Aug 2026

Retained earnings remains negative

Q1 FY2027 retained earnings was -$556.2M, compared with -$500.09M a year earlier.

Context

  • Retained earnings amounted to 16.8% of total assets at the end of Q1 FY2027, up 2.0 pp from a year earlier.
  • Retained earnings increased in 0 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -11.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterAug 2026
-$556.2M-2.2% QoQ
Last fiscal yearMay 2026
-$544.3M-1.5% YoY
Year agoAug 2025
-$500.09M-11.2% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-11.2%——
1 year-1.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2026
(544.3M) USD
Year-over-year change
-1.5%

Retained Earnings vs competitors

How NEOG compares with its peers on the latest reported figures

  • NEOG's Aug 2026 retained earnings of -$556.2M is the 6th highest of the 7 companies compared; the peer median is $4.29B.
  • Its year-over-year change of -11.2% is the lowest of 7, against a peer median of +13.2%.
  • Retained earnings amounts to 16.8% of total assets for NEOG, versus a peer median of 61.1%.
NEOG Competitors Peer median
Retained Earnings for NEOG and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MRKMerck & Co., Inc.Jun 2026$63.27B -7.6%+6.2%48.7%
ZTSZoetis Inc.Jun 2026$14.65B +13.8%+16.6%97.2%
IDXXIDEXX Laboratories, Inc.Sep 2026$7.33B +19.2%+21.1%197.6%
BCPCBalchem CorporationSep 2026$1.25B +12.6%+11.2%73.6%
PAHCPhibro Animal Health CorporationMar 2026$336.12M +29.1%+3.3%23.3%
NEOGNeogen CorporationAug 2026-$556.2M -11.2%—16.8%
ELANElanco Animal Health IncorporatedSep 2026-$2.05B -7.7%—15.4%
Peer median (excluding NEOG) $4.29B+13.2%+11.2%61.1%

Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Cash & Equivalents44.47M163.24M170.61M129M185.5M
Short-term Investments336.58M82.33M325K00
Net Receivables99.67M153.25M173.01M153.38M146.8M
Inventory122.31M133.81M189.27M190.86M144.3M
Other Current Assets053.3M56.03M103.69M128M
Total Current Assets626.8M585.93M589.23M576.94M604.6M
Property, Plant & Equipment (Net)110.58M198.75M291.89M356.28M497M
Goodwill142.7M2.14B2.14B1.06B1.05B
Intangible Assets107.5M1.61B1.51B1.41B1.32B
Long-term Investments00229K00
Tax Assets6.93M19.39M000
Other Non-current Assets(1.59M)7.77M20.2M35.23M(120.8M)
Total Non-current Assets366.13M3.97B3.96B2.87B2.74B
Total Assets992.93M4.55B4.55B3.44B3.35B
Account Payables34.61M76.67M83.06M79.61M79.1M
Short-term Debt002.45M19.3M0
Tax Payables2.13M6.95M10.45M5.6M7.2M
Deferred Revenue5.46M4.62M4.63M5.56M3.6M
Other Current Liabilities11.12M28.81M26.24M44.8M57.3M
Total Current Liabilities77.84M145.47M154.32M174.01M158.2M
Long-term Debt0885.44M888.39M874.81M793.7M
Deferred Tax Liabilities17.01M353.43M326.72M280.91M257.6M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities10.7M27.07M24.96M29.99M43.6M
Total Non-current Liabilities27.71M1.27B1.25B1.2B1.09B
Total Liabilities105.56M1.42B1.4B1.37B1.25B
Common Stock17.25M34.6M34.66M34.73M34.8M
Retained Earnings587.91M565.04M555.62M(536.42M)(544.3M)
Accumulated OCI(27.77M)(33.25M)(30.02M)(28.9M)(13.6M)
Other Stockholders Equity00002.62B
Minority Interest00000
Total Equity887.37M3.13B3.14B2.07B2.09B
Total Debt0897.53M906.24M912.61M793.7M
Net Debt(44.47M)734.29M735.63M783.61M608.2M

Neogen Corporation

NASDAQ:NEOG

Intrinsic Alpha fair value

Locked

Current Price

$11.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.